A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype.

Our previous studies demonstrated that Wnt/GSK-3/β-catenin and mTOR signaling are necessary to stimulate proliferative processes in adult human β-cells. Direct inhibition of GSK-3, that engages Wnt signaling downstream of the Wnt receptor, increases β-catenin nuclear translocation and β-cell prolife...

Full description

Bibliographic Details
Main Authors: Haytham Aly, Nidhi Rohatgi, Connie A Marshall, Tiffani C Grossenheider, Hiroyuki Miyoshi, Thaddeus S Stappenbeck, Scot J Matkovich, Michael L McDaniel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3680388?pdf=render
_version_ 1818061121076068352
author Haytham Aly
Nidhi Rohatgi
Connie A Marshall
Tiffani C Grossenheider
Hiroyuki Miyoshi
Thaddeus S Stappenbeck
Scot J Matkovich
Michael L McDaniel
author_facet Haytham Aly
Nidhi Rohatgi
Connie A Marshall
Tiffani C Grossenheider
Hiroyuki Miyoshi
Thaddeus S Stappenbeck
Scot J Matkovich
Michael L McDaniel
author_sort Haytham Aly
collection DOAJ
description Our previous studies demonstrated that Wnt/GSK-3/β-catenin and mTOR signaling are necessary to stimulate proliferative processes in adult human β-cells. Direct inhibition of GSK-3, that engages Wnt signaling downstream of the Wnt receptor, increases β-catenin nuclear translocation and β-cell proliferation but results in lower insulin content. Our current goal was to engage canonical and non-canonical Wnt signaling at the receptor level to significantly increase human β-cell proliferation while maintaining a β-cell phenotype in intact islets. We adopted a system that utilized conditioned medium from L cells that expressed Wnt3a, R-spondin-3 and Noggin (L-WRN conditioned medium). In addition we used a ROCK inhibitor (Y-27632) and SB-431542 (that results in RhoA inhibition) in these cultures. Treatment of intact human islets with L-WRN conditioned medium plus inhibitors significantly increased DNA synthesis ∼6 fold in a rapamycin-sensitive manner. Moreover, this treatment strikingly increased human β-cell proliferation ∼20 fold above glucose alone. Only the combination of L-WRN conditioned medium with RhoA/ROCK inhibitors resulted in substantial proliferation. Transcriptome-wide gene expression profiling demonstrated that L-WRN medium provoked robust changes in several signaling families, including enhanced β-catenin-mediated and β-cell-specific gene expression. This treatment also increased expression of Nr4a2 and Irs2 and resulted in phosphorylation of Akt. Importantly, glucose-stimulated insulin secretion and content were not downregulated by L-WRN medium treatment. Our data demonstrate that engaging Wnt signaling at the receptor level by this method leads to necessary crosstalk between multiple signaling pathways including activation of Akt, mTOR, Wnt/β-catenin, PKA/CREB, and inhibition of RhoA/ROCK that substantially increase human β-cell proliferation while maintaining the β-cell phenotype.
first_indexed 2024-12-10T13:43:16Z
format Article
id doaj.art-5fd82f224eb0466dbcad8713a11f8da7
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T13:43:16Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5fd82f224eb0466dbcad8713a11f8da72022-12-22T01:46:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0186e6613110.1371/journal.pone.0066131A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype.Haytham AlyNidhi RohatgiConnie A MarshallTiffani C GrossenheiderHiroyuki MiyoshiThaddeus S StappenbeckScot J MatkovichMichael L McDanielOur previous studies demonstrated that Wnt/GSK-3/β-catenin and mTOR signaling are necessary to stimulate proliferative processes in adult human β-cells. Direct inhibition of GSK-3, that engages Wnt signaling downstream of the Wnt receptor, increases β-catenin nuclear translocation and β-cell proliferation but results in lower insulin content. Our current goal was to engage canonical and non-canonical Wnt signaling at the receptor level to significantly increase human β-cell proliferation while maintaining a β-cell phenotype in intact islets. We adopted a system that utilized conditioned medium from L cells that expressed Wnt3a, R-spondin-3 and Noggin (L-WRN conditioned medium). In addition we used a ROCK inhibitor (Y-27632) and SB-431542 (that results in RhoA inhibition) in these cultures. Treatment of intact human islets with L-WRN conditioned medium plus inhibitors significantly increased DNA synthesis ∼6 fold in a rapamycin-sensitive manner. Moreover, this treatment strikingly increased human β-cell proliferation ∼20 fold above glucose alone. Only the combination of L-WRN conditioned medium with RhoA/ROCK inhibitors resulted in substantial proliferation. Transcriptome-wide gene expression profiling demonstrated that L-WRN medium provoked robust changes in several signaling families, including enhanced β-catenin-mediated and β-cell-specific gene expression. This treatment also increased expression of Nr4a2 and Irs2 and resulted in phosphorylation of Akt. Importantly, glucose-stimulated insulin secretion and content were not downregulated by L-WRN medium treatment. Our data demonstrate that engaging Wnt signaling at the receptor level by this method leads to necessary crosstalk between multiple signaling pathways including activation of Akt, mTOR, Wnt/β-catenin, PKA/CREB, and inhibition of RhoA/ROCK that substantially increase human β-cell proliferation while maintaining the β-cell phenotype.http://europepmc.org/articles/PMC3680388?pdf=render
spellingShingle Haytham Aly
Nidhi Rohatgi
Connie A Marshall
Tiffani C Grossenheider
Hiroyuki Miyoshi
Thaddeus S Stappenbeck
Scot J Matkovich
Michael L McDaniel
A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype.
PLoS ONE
title A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype.
title_full A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype.
title_fullStr A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype.
title_full_unstemmed A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype.
title_short A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype.
title_sort novel strategy to increase the proliferative potential of adult human β cells while maintaining their differentiated phenotype
url http://europepmc.org/articles/PMC3680388?pdf=render
work_keys_str_mv AT haythamaly anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT nidhirohatgi anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT connieamarshall anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT tiffanicgrossenheider anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT hiroyukimiyoshi anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT thaddeussstappenbeck anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT scotjmatkovich anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT michaellmcdaniel anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT haythamaly novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT nidhirohatgi novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT connieamarshall novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT tiffanicgrossenheider novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT hiroyukimiyoshi novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT thaddeussstappenbeck novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT scotjmatkovich novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT michaellmcdaniel novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype